Abstract
This article focuses on the regulation of GLI2 by LINC02560 in HCC. Revealing this mechanism provides a new perspective for the morbidity mechanism and treatment strategy of hepatocellular carcinoma.LINC02560, a long non-coding RNA (lncRNA), is upregulated in hepatocellular carcinoma through interaction with GLI2 protein. They jointly regulate key biological processes such as cell proliferation, invasion, migration and apoptosis. It was found that LINC02560 not only directly binds to GLI2 protein, It also plays a regulatory role by affecting the epigenetic modification of GLI2 gene and the interaction with other transcription factors. These mechanisms contribute to the initiation and progression of HCC. In addition, the expression level of LINC02560 is closely related to the therapeutic effect and prognosis of hepatocellular carcinoma. It provides an important basis for the formulation of individualized treatment plan. Therefore, the study of GLI2 regulation by LINC02560 not only deepens our understanding of the mechanism of morbidity in hepatocellular carcinoma, It also provides important clues for finding new therapeutic targets and improving therapeutic effects.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Affiliated Hospital of Youjiang Medical University for Nationalities, Department of Pathology, Baise, China (GRID:grid.460081.b); Key Laboratory of Molecular Pathology in Tumors of Guangxi Higher Education Institutions, Baise, China (GRID:grid.460081.b)
2 Youjiang Medical University for Nationalities, Baise, China (GRID:grid.410618.a) (ISNI:0000 0004 1798 4392)